Your browser version may not work well with NCBI's Web applications. More information
here...
-
Molecular definition of breast tumor heterogeneity.
Shipitsin M,
Campbell LL,
Argani P,
Weremowicz S,
Bloushtain-Qimron N,
Yao J,
Nikolskaya T,
Serebryiskaya T,
Beroukhim R,
Hu M,
Halushka MK,
Sukumar S,
Parker LM,
Anderson KS,
Harris LN,
Garber JE,
Richardson AL,
Schnitt SJ,
Nikolsky Y,
Gelman RS,
Polyak K.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Cells with distinct phenotypes including stem-cell-like properties have been proposed to exist in normal human mammary epithelium and breast carcinomas, but their detailed molecular characteristics and clinical significance are unclear. We determined gene expression and genetic profiles of cells purified from cancerous and normal breast tissue using markers previously associated with stem-cell-like properties. CD24+ and CD44+ cells from individual tumors were clonally related but not always identical. CD44+ cell-specific genes included many known stem-cell markers and correlated with decreased patient survival. The TGF-beta pathway was specifically active in CD44+ cancer cells, where its inhibition induced a more epithelial phenotype. Our data suggest prognostic relevance of CD44+ cells and therapeutic targeting of distinct tumor cell populations.
PMID: 17349583 [PubMed - indexed for MEDLINE]
-
Related Articles